Consumer & Travel Stock News
Sunday, April 05, 2026
Lilly's New Obesity Pill Launches Tomorrow — But Can It Justify a $935 Stock Price in a Price War With Novo?
Shares shifted as Eli Lilly secured FDA approval on April 1 for its once-daily weight-loss pill, the first oral obesity drug patients can take at any time...
Eli Lilly Wins FDA Approval for Foundayo, a Flexible Obesity Pill
The FDA approved Eli Lilly’s once-daily weight-loss pill, Foundayo (orforglipron), on April 1, 2026. This drug is the first oral GLP-1 for weight management...
JetBlue Downgraded to CCC+ as Fitch Flags Prolonged Financial Recovery
Fitch Ratings downgraded JetBlue Airways' Long-Term Issuer Default Rating to 'CCC+' from 'B-'. The agency cited persistent operating losses and a...
Netflix must refund Italian subscribers, following court ruling on illegal price hikes
A Rome court ruled Netflix’s price increases over the last seven years unlawful. The court found contract clauses allowing hikes without valid reasons violated...
Paramount Skydance President Jeff Shell negotiates exit, following gambler lawsuit
United Airlines Reaches Labor Deal, Boosting Senior Pay Above $100 Hourly
Huawei secures bulk AI chip orders, fueling China’s next-gen DeepSeek model
Amazon tightens discount rules, fighting lawsuits over deceptive Prime Day pricing
Other News
Amazon Ordered to Bargain With Staten Island Union, Retailer Vows Appeal
Wells Fargo Slashes Its PSKY Target to $8 — But Can Wall Street's Bearish Consensus Survive a Stock That Refuses to Stay Down?
Alibaba launches Qwen3.6-Plus, targeting autonomous coding to drive AI revenue
Delta's Engine Fire Streak Deepens as Shares Slide — Is the Airline's Safety Record Becoming a Valuation Problem?
Ford Reports Q1 2026 Sales Decline of 8.8%, Cites Strong SUV Growth
Amazon Eyes Globalstar to Boost Project Kuiper, Rivaling SpaceX Starlink
AWS Bahrain Facility Damaged, Hit by Iranian Drone Strike
Booking Holdings Appoints Former NXP CEO Kurt Sievers to Board of Directors
Amazon's New Rufus AI Ads Prove Highly Cost-Effective in Beta as Paid Model Begins
Eli Lilly's $7.8 Billion Sleep-Drug Bet and AI Push: Is the GLP-1 Cash Machine Building a New Empire or Buying Growth It Cannot Organically Create?
OpenAI hits $852B valuation, raising record $122B to fuel AI growth
Nike's third quarter 2026 EPS and revenue beat estimates, led by better-than-expected Greater China performance.
Amazon.com stock closes up 3.64% on March 31 amid market rebound
Delta Bets on Amazon's Satellites for Faster In-Flight Wi-Fi — But Can a 2028 Promise Move the Stock Today?
Amazon Replaces American Express With U.S. Bank for Business Credit Cards
Amazon wins Delta satellite internet deal, challenging SpaceX
U.S. Treasury Yields Plunge on Recession Fears
Alibaba Launches Qwen3.5-Omni, Outperforming Google in Audio Benchmarks
Attacks on Mideast Aluminum Plants Threaten Supply Crisis
Oil Prices Record Largest Monthly Surge in History
Nike Inc Q1 2026 Earnings Preview: What Analysts Expect on March 31, 2026
Amazon Slides Below $200, Hit by $200B AI Spending Concerns
Eli Lilly strikes $2.75B AI deal with Insilico for diabetes treatments